Tumour-associated macrophages process drug and radio-conjugates of the dead tumour cell-targeting APOMAB® antibody-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumour-associated macrophages process drug and radio-conjugates of the dead tumour cell-targeting APOMAB® antibody

Published:2020-11 Issue: Volume:327 Page:779-787
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Staudacher Alexander H.,Liapis Vasilios,Tieu William,Wittwer Nicole L.,Brown Michael P.

Funder

National Health and Medical Research Council

AusHealth Research Pty Ltd.

Australian National Imaging Facility Fellowship

National Biologics Facility

Australian Government's National Collaborative Research Infrastructure Scheme

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference46 articles.

1. Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?;Staudacher;Br. J. Cancer,2017

2. Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression;Jacobsen;Blood,2015

3. Objective responses in relapsed T-cell lymphomas with single agent brentuximab vedotin;Horwitz;Blood,2014

4. Results of a phase II trial of Brentuximab Vedotin for CD30+ cutaneous T-cell lymphoma and Lymphomatoid Papulosis;Duvic;J. Clin. Oncol.,2015

5. Expression of CD30 as a biomarker to predict response to brentuximab vedotin;Xu;Histopathology,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer;Journal for ImmunoTherapy of Cancer;2023-03

2. Fc gamma receptor is not required for in vivo processing of radio- and drug-conjugates of the dead tumor cell-targeting monoclonal antibody, APOMAB®;Biomedicine & Pharmacotherapy;2022-07

3. The RNA ‐binding protein La/ SSB associates with radiation‐induced DNA double‐strand breaks in lung cancer cell lines;Cancer Reports;2021-10-12

4. Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models;Molecular Imaging and Biology;2021-07-06

5. Quantifying ADC bystander payload penetration with cellular resolution using pharmacodynamic mapping;Neoplasia;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3